Skip to main content
All lobbying filings

BELL & LINDSAY, INC.

Lobbying for OYE THEREPEUTICS · Pharmaceutical, development stage, company

 Filing 3rd Quarter - Report
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Oct 20, 2025
Income
$10,000.00
What the client paid this registrant for the period.
Client based in
Indiana

Official filing document

 Lobbyists on this filing 1
  • MARK F LINDSAY
    Previously held: US House Staff

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 9
  • Defense, Dept of (DOD)
  • Executive Office of the President (EOP)
  • Food & Drug Administration (FDA)
  • Health & Human Services, Dept of (HHS)
  • HOUSE OF REPRESENTATIVES
  • Office of Management & Budget (OMB)
  • Office of Natl Drug Control Policy (NDCP)
  • Office of Science & Technology Policy (OSTP)
  • SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Lobbying activity 1
Health Issues

General Consulting and informing federal agencies and Congress on the research that OYE Therapeutics is currently doing.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem